A press release of the phase 2 obesity trial (MOMENTUM-1) reports a mean WL up to 15.6% (placebo-adjusted 13.4%) at 48 weeks with the 2.4 mg dose
The Clinical Bottom Line The answer to what is GHK-Cu is also the answer to why it matters: it is the bodys own repair signal, and most people over 30 are running it at a significant deficit
These findings come despite other recent studies showing an increased risk of suicidal ideation among people with anxiety or depression who take semaglutide, compared to other diabetes drugs
Supplements should refine a good routine, not rescue a shaky one. DVM Voice: Clinical Vignette of When Skin Changes Point Deeper Than the Surface Case contributed by Sarah Calvin, DVM Rosey, a 10-year-old Shih Tzu, was brought in after two weeks of paw redness and head shaking
Comparing PT-141 to Traditional Erectile Dysfunction Treatments When considering treatments for erectile dysfunction, it can be helpful to see how PT-141 compares with traditional options such as PDE5 inhibitors (e.g., Viagra, Cialis)
Keep in mind that markets are volatile: LLY shares can move both for and against an open position